This compound is primarily utilized in the development of pharmaceutical agents, particularly in the field of oncology. It functions as a potent inhibitor of specific protein-protein interactions that are critical in cancer cell signaling pathways. By disrupting these interactions, it can effectively halt the proliferation of cancer cells, making it a valuable candidate for targeted cancer therapies. Additionally, its unique structure allows for high selectivity and binding affinity, which minimizes off-target effects and enhances its therapeutic potential. Researchers are also exploring its application in treating other diseases where abnormal protein interactions play a key role, such as certain autoimmune disorders and neurodegenerative conditions. Its ability to modulate specific molecular targets makes it a promising compound for further drug development and clinical studies.